0
Original Research: PULMONARY HYPERTENSION |

A Nuclear Factor-κB Inhibitor Pyrrolidine Dithiocarbamate Ameliorates Pulmonary Hypertension in Rats*

Hirofumi Sawada, MD; Yoshihide Mitani, MD, PhD; Junko Maruyama, MD, PhD; Bao Hua Jiang, MD, PhD; Yukiko Ikeyama, MD; Francis A. Dida, MD; Hatsumi Yamamoto, MD, PhD; Kyoko Imanaka-Yoshida, MD, PhD; Hideto Shimpo, MD, PhD; Akira Mizoguchi, MD, PhD; Kazuo Maruyama, MD; Yoshihiro Komada, MD, PhD
Author and Funding Information

*From the Departments of Pediatric and Developmental Science (Drs. Sawada, Mitani, Ikeyama, Dida, and Komada), Physiology (Dr. J. Maruyama), Anesthesiology (Drs. Jiang and K. Maruyama), Pathology and Matrix Biology (Dr. Imanaka-Yoshida), Thoracic and Cardiovascular Surgery (Dr. Shimpo), and Neural Regeneration and Cell Communication (Dr. Mizoguchi), Mie University Graduate School of Medicine, Tsu City, Japan; and Clinical Research Institute (Dr. Yamamoto), Mie-chuo Medical Center, National Hospital Organization, Tsu City, Mie, Japan.

Correspondence to: Yoshihide Mitani, MD, PhD, Department of Pediatric and Developmental Science, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu city, Mie Prefecture, 514-8507, Japan; e-mail: ymitani@clin.medic.mie-u.ac.jp



Chest. 2007;132(4):1265-1274. doi:10.1378/chest.06-2243
Text Size: A A A
Published online

Background: Pulmonary hypertension (PH) is a fatal disorder that is associated with structural changes and inflammatory responses in the pulmonary vasculature. Nuclear factor (NF)-κB is a key transcription factor that is involved in the tissue remodeling mediated by inflammatory and fibroproliferative responses. However, the contribution of NF-κB-mediated inflammatory pathways to the development of PH is unknown.

Methods: We therefore investigated whether NF-κB activation and the expression of a downstream product vascular cell adhesion molecule (VCAM)-1 is associated with pulmonary vascular diseases in rats that have been injected with the toxin monocrotaline (MCT), and whether a NF-κB inhibitor, pyrrolidine dithiocarbamate (PDTC), ameliorates such diseases in rats.

Results: VCAM-1 expression and the nuclear localization of the p65 subunit of NF-κB, as analyzed immunohistochemically, was significantly up-regulated in the endothelium of diseased vessels on the days 8 to 22 (p < 0.05). Next, 39 rats were divided into three groups (rats injected with MCT and treated with saline solution or PDTC, and controls similarly treated with saline solution). Compared to controls, MCT treatment increased the mean (± SE) pulmonary artery pressure (31.2 ± 1.4 mm Hg [p < 0.05] vs 22.8 ± 0.9 mm Hg, respectively), which was reduced by PDTC treatment (24.3 ± 1.2 mm Hg; p < 0.05). Indexes of right ventricular hypertrophy and pulmonary vascular diseases induced by MCT were similarly inhibited (p < 0.05), which was associated with the suppression of VCAM-1 expression and macrophage infiltration.

Conclusions: We concluded that the NF-κB nuclear localization and VCAM-1 expression is temporally and spatially associated with the development of MCT-induced PH in rats, which was ameliorated by administering a NF-κB inhibitor, PDTC.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543